MedTrace Logo

Hypofractionated Brain Radiationcavity

NCT03561896 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2024-07-17

No results posted yet for this study

Summary

Stereotactic radiosurgery or hypofractionated radiotherapy of the resection cavity after metastasectomy in cancer patients with brain metastases

Conditions

  • Brain Metastases, Adult
  • Cancer Brain

Interventions

RADIATION

IGRT

Image-Guided Radiation Therapy

RADIATION

SRS

stereotactic radiation therapy

Sponsors & Collaborators

  • Oncology Institute of Southern Switzerland

    lead OTHER

Principal Investigators

  • Gianfranco A Pesce, MD · IOSI, Bellinzona, Switzerland

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2024-06-18
Completion
2024-06-18

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03561896 on ClinicalTrials.gov